lactic acid has been researched along with zidovudine in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (24.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 7 (28.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Cheema-Dhadli, S; Gopinath, R; Halperin, M; Hutcheon, M | 1 |
Hobbs, GA; Keilbaugh, SA; Rief, PM; Simpson, MV | 1 |
de Martino, M; Donati, MA; Filippi, L; Galli, L; Mannelli, F; Vierucci, A; Zammarchi, E | 1 |
Boal, JH; Miller, RK; Plessinger, MA; van den Reydt, C | 1 |
Agarwal, RP; Olivero, OA | 1 |
Barnett, T; Eidelberg, D; Frank, Y; Hyman, RA; Lu, D; Pavlakis, SG; Wiznia, A | 1 |
Burlina, A; D'Elia, R; De Romeo, A; De Rossi, A; Giacomet, V; Giaquinto, C; Rampon, O; Ruga, E; Sturkenboom, M | 1 |
Corzo, JE; Gómez-Mateos , J; Lozano, F; Ramayo, E | 1 |
Haase, CP; Hoit, BD; Lewis, W; Raidel, SM; Russ, RB; Samarel, AM; Sutliff, RL | 1 |
Alimenti, A; Burdge, DR; Forbes, JC; Money, DM; Ogilvie, GS | 1 |
Biour, M; Djouadi, F; Fromenty, B; Guimont, MC; Igoudjil, A; Lettéron, P; Maisonneuve, C; Note, R; Pessayre, D; Peytavin, G | 1 |
Koopmans, PP; ter Hofstede, HJ; Willems, HL | 1 |
Amin, S; Civin, CI; Lewis, LD; Lietman, PS | 1 |
Artuch, R; Fortuny, C; Jimenez, R; Muñoz-Almagro, C; Noguera, A; Pou, J; Sanchez, E; Vilaseca, MA | 1 |
Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC | 1 |
Bastow, B; Glesby, MJ; Gulick, RM; Kuritzkes, DR; Meyer, WA; Ribaudo, HJ; Shikuma, CM; Tashima, KT; Webb, N; Yang, Y | 1 |
Bassit, L; Detorio, MA; Dikalov, S; Hernandez-Santiago, BI; Jones, DP; Kleinhenz, DJ; Kline, ER; Liang, B; Schinazi, RF; Sutliff, RL; Walp, ER | 1 |
Gremião, MP; Khalil, NM; Mainardes, RM | 1 |
Chen, H; Hu, M; Jiang, Z; Li, Z; Tao, Y; Xiong, Y; Zhang, L; Zhang, P | 1 |
Esteban-Cruciani, N; Hoffman, RS; Lee, S; Livshits, Z; Nelson, LS | 1 |
Ajitkumar, GN; Hariharan, S; Nareshkumar, PN; Penmetsa, SD; Sankar, V | 1 |
Contado, C; Dalpiaz, A; Hanuskovà, M; Leo, E; Mari, L; Paganetto, G; Pavan, B; Perrone, D; Vighi, E | 1 |
Aranha, N; Balcão, VM; Chaud, MV; Gremião, MP; Oliveira Júnior, JM; Vila, MM; Yoshida, VM | 1 |
3 trial(s) available for lactic acid and zidovudine
Article | Year |
---|---|
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
Topics: Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Lamivudine; Male; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine | 2006 |
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Glucose; Body Composition; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Insulin Resistance; Lactic Acid; Lamivudine; Lipids; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
22 other study(ies) available for lactic acid and zidovudine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Exercise; Humans; Kidney; Lactates; Lactic Acid; Male; Mitochondrial Myopathies; Zidovudine | 1992 |
Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation.
Topics: Adenosine Triphosphate; Animals; Cell Division; Cell Line; Cytosol; Dideoxynucleosides; DNA Replication; DNA, Mitochondrial; Lactates; Lactic Acid; Mice; Mitochondria; Oxidative Phosphorylation; Oxygen; Protein Biosynthesis; Time Factors; Zidovudine | 1995 |
Redox potential status in children with perinatal HIV-1 infection treated with zidovudine.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Hydroxybutyrates; Infant; Infectious Disease Transmission, Vertical; Lactates; Lactic Acid; Male; Mitochondria; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Zidovudine | 1995 |
Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours.
Topics: Anti-HIV Agents; Chorionic Gonadotropin; Female; Glucose; Humans; In Vitro Techniques; Lactic Acid; Maternal-Fetal Exchange; Oxygen; Perfusion; Placenta; Pregnancy; Pregnancy Trimester, Third; Tissue Distribution; Zidovudine | 1997 |
Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine.
Topics: Anti-HIV Agents; Cell Nucleus; Cells, Cultured; Chromosome Aberrations; DNA Adducts; DNA Damage; DNA, Mitochondrial; Humans; Lactic Acid; Lipid Metabolism; Micronuclei, Chromosome-Defective; Mitochondria; Mutagenicity Tests; Radioimmunoassay; T-Lymphocytes; Zidovudine | 1997 |
Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Aspartic Acid; Brain; Child; Child, Preschool; Creatine; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurologic Examination; Zidovudine | 1998 |
[Symptomatic hyperlactemia in patients infected with the human immunodeficiency virus treated with nucleoside analogs].
Topics: Adult; Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Lactic Acid; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Calcium-Transporting ATPases; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Gene Expression; HIV Protease Inhibitors; Indinavir; Lactic Acid; Lamivudine; Mice; Mice, Transgenic; Microscopy, Electron; Myocardium; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Zidovudine | 2001 |
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Topics: Acidosis, Lactic; Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Confidence Intervals; Female; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Male; Monitoring, Physiologic; Odds Ratio; Perinatal Care; Pregnancy; Probability; Prognosis; Prospective Studies; Risk Assessment; Zidovudine | 2003 |
Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.
Topics: Aminoisobutyric Acids; Animals; Blotting, Northern; Cholesterol; DNA; Fatty Acids; Immunoblotting; Ketone Bodies; Lactic Acid; Lipid Metabolism; Liver; Male; Metabolism; Mice; Mitochondria; Oxidation-Reduction; Phospholipids; Pyruvic Acid; Reverse Transcriptase Inhibitors; Thymidine; Triglycerides; Zidovudine | 2003 |
Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.
Topics: Adult; Anti-HIV Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Lactic Acid; Male; Mitochondria; Pyruvic Acid; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production.
Topics: Anti-HIV Agents; Antigens, CD34; Cell Differentiation; Cell Proliferation; Cells, Cultured; DNA, Mitochondrial; Dose-Response Relationship, Drug; Erythrocytes; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoblotting; Lactic Acid; Zidovudine | 2004 |
Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Topics: Alanine; Antiretroviral Therapy, Highly Active; Didanosine; Female; HIV Infections; HIV Seronegativity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Logistic Models; Male; Mitochondria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction.
Topics: Biomarkers; Cell Death; Cell Line, Tumor; Cells, Cultured; DNA, Mitochondrial; Endothelial Cells; Glutathione; Humans; Lactic Acid; Membrane Potential, Mitochondrial; Mitochondria; Mitochondria, Liver; Oxidative Stress; Phosphorylation; Reverse Transcriptase Inhibitors; Stavudine; Superoxides; Time Factors; Zidovudine | 2009 |
Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
Topics: Administration, Intranasal; Animals; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Half-Life; Lactic Acid; Male; Mice; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Surface Properties; Technology, Pharmaceutical; Zidovudine | 2010 |
Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.
Topics: Acidosis, Lactic; Animals; Antiviral Agents; Dideoxynucleosides; DNA, Mitochondrial; Fatty Liver; Hepatitis B; Hepatitis B virus; Lactic Acid; Marmota; Mitochondria; Prodrugs; Purine Nucleosides; Zidovudine | 2011 |
Zidovudine (AZT) overdose in a healthy newborn receiving postnatal prophylaxis.
Topics: Acidosis; Alanine Transaminase; Anti-HIV Agents; Drug Overdose; HIV Infections; Humans; Infant, Newborn; Lactic Acid; Male; Medication Errors; Neutropenia; Zidovudine | 2011 |
Comparative studies of lamivudine-zidovudine nanoparticles for the selective uptake by macrophages.
Topics: Animals; Anti-HIV Agents; Drug Carriers; Drug Combinations; Lactic Acid; Lamivudine; Lipids; Macrophages; Male; Mice; Nanoparticles; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Reverse Transcriptase Inhibitors; Surface-Active Agents; Tissue Distribution; Zidovudine | 2012 |
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.
Topics: Animals; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Hydrolysis; Kinetics; Lactic Acid; Liver; Male; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Rats, Wistar; Reverse Transcriptase Inhibitors; Solubility; Surface Properties; Technology, Pharmaceutical; Ursodeoxycholic Acid; Zidovudine | 2014 |
Zidovudine-poly(L-lactic acid) solid dispersions with improved intestinal permeability prepared by supercritical antisolvent process.
Topics: Animals; Chromatography, Supercritical Fluid; Intestinal Absorption; Lactic Acid; Male; Permeability; Rats; Rats, Wistar; Solvents; Zidovudine | 2015 |